152
Participants
Start Date
February 15, 2023
Primary Completion Date
July 13, 2024
Study Completion Date
July 25, 2024
ARV-471
100 mg tablet
Anastrozole
1 mg tablet
Surgical resection of breast tumor
Surgical resection approximately 5.5 months after starting treatment (C6D18 ± 14 days)
Clinical Trial Site, Batumi
Clinical Trial Site, Castelló
Clinical Trial Site, Berlin
Clinical Trial Site, Córdoba
Clinical Trial Site, A Coruña
Clinical Trial Site, Granada
Clinical Trial Site, Granada
Clinical Trial Site, Lleida
Clinical Trial Site, Madrid
Clinical Trial Site, Madrid
Clinical Trial Site, Madrid
Clinical Trial Site, Orlando
Clinical Trial Site, Paderborn
Clinical Trial Site, Fort Lauderdale
Clinical Trial Site, West Palm Beach
Clinical Trial Site, Fort Myers
Clinical Trial Site, Nashville
Clinical Trial Site, San Cristóbal de La Laguna
Clinical Trial Site, Seville
Clinical Trial Site, Seville
Clinical Trial Site, Essen
Clinical Trial Site, Valencia
Clinical Trial Site, Valencia
Clinical Trial Site, Bottrop
Clinical Trial Site, Zaragoza
Clinical Trial Site, Iowa City
Clinical Trial Site, Bonn
Clinical Trial Site, St Louis
Clinical Trial Site, Mannheim
Clinical Trial Site, Springdale
Clinical Trial Site, Esslingen am Neckar
Clinical Trial Site, Augsburg
Clinical Trial Site, Los Angeles
Clinical Trial Site, Torrance
Clinical Trial Site, Erlangen
Clinical Trial Site, Van Nuys
Clinical Trial Site, Tacoma
Clinical Trial Site, Essen
Clinical Trial Site, Springfield
Clinical Trial Site, Tbilisi
Clinical Trial Site, Tbilisi
Clinical Trial Site, Tbilisi
Clinical Trial Site, Chemnitz
Clinical Trial Site, Dresden
Clinical Trial Site, Alicante
Clinical Trial Site, Barcelona
Clinical Trial Site, Barcelona
Clinical Trial Site, Barcelona
Clinical Trial Site, Manresa
Lead Sponsor
Collaborators (1)
Pfizer
INDUSTRY
Arvinas Inc.
INDUSTRY